PVR and acute myeloid leukemia: Although CD155 expression was also detected in a subset of hematopoietic stem and progenitor cells (HSPCs) from healthy donors, its level, both in terms of the percentage of positive cells and MFI, was significantly lower than the levels in LSCs from patients with AML (Figure 1C).